Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.740 | ||||||
REV | 15.680M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ZYME | Zymeworks | 37.45 | -2.85 | -7.07% | 1.7B |
You can purchase shares of Zymeworks (NYSE: ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: ADC Therapeutics (NYSE:ADCT), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Zymeworks (NYSE: ZYME) was reported by SVB Leerink on 2021-02-25. The analyst firm set a price target for 41.00 expecting ZYME to rise to within 12 months (a possible 9.48% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Zymeworks (NYSE: ZYME) is $37.45 last updated Thu Feb 25 2021 20:59:58 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Zymeworks.
There is no upcoming split for Zymeworks.